Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 23, 2024AgingOpen Access

Targeting tumor-associated macrophages to reverse antitumor drug resistance

View Full Paper
Ask AI
Bookmark
Share

Authors

LSLi ShengNingbo UniversityJSJiyao ShengJilin UniversityDZDan ZhangWuhan Union Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Sheng et al. (2024) studied this question.

synapsesocial.com/papers/68e68ab9b6db643587612bd6https://doi.org/10.18632/aging.205858
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade2019 · 825 citations
  2. 2A Paracrine Loop between Tumor Cells and Macrophages Is Required for Tumor Cell Migration in Mammary Tumors2004 · 1,206 citations
  3. 3Increased Antiangiogenic Effect by Blocking CCL2-dependent Macrophages in a Rodent Glioblastoma Model: Correlation Study with Dynamic Susceptibility Contrast Perfusion MRI2019 · 73 citations
  4. 4Lessons From Anti–Vascular Endothelial Growth Factor and Anti–Vascular Endothelial Growth Factor Receptor Trials in Patients With Glioblastoma2015 · 180 citations